Amphion pumps $1m into US medical imaging company:
This article was originally published in Clinica
Executive Summary
London, UK-based life science company Amphion Innovations has invested $1m to up its stake in Supertron Technologies, a private US medical imaging firm, to 30%. Spun out from New York's Columbia University, Supertron is currently developing a range of next-generation MRI (magnetic resonance imaging) scanners used for neuro- and pre-clinical imaging. According to Amphion, Supertron's scanners offer enhanced quality images more quickly and at a lower cost than conventional MRI devices. The Newark, New Jersey company - headed by Richard Hullihen, formerly of GEC-Picker International and Marconi Medical Systems - is also targeting emerging MRI research applications in the fields of molecular imaging, image-guided therapeutics, image-guided surgery and orthopaedics imaging.